These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8977279

  • 21. Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes.
    Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, Newsom-Davis J.
    J Clin Invest; 1994 Apr; 93(4):1361-9. PubMed ID: 7512979
    [Abstract] [Full Text] [Related]

  • 22. Experimental myasthenia gravis in congenic mice. Sequence mapping and H-2 restriction of T helper epitopes on the alpha subunits of Torpedo californica and murine acetylcholine receptors.
    Bellone M, Ostlie N, Lei S, Conti-Tronconi BM.
    Eur J Immunol; 1991 Oct; 21(10):2303-10. PubMed ID: 1680694
    [Abstract] [Full Text] [Related]

  • 23. B-T lymphocyte interactions in experimental autoimmune myasthenia gravis: autoantibody mediated up-regulation of the response of acetylcholine receptor-specific T lymphocytes.
    Zhang Y, Tzartos S.
    Immunology; 1992 Dec; 77(4):571-6. PubMed ID: 1283599
    [Abstract] [Full Text] [Related]

  • 24. T cells from normal and myasthenic individuals recognize the human acetylcholine receptor: heterogeneity of antigenic sites on the alpha-subunit.
    Melms A, Malcherek G, Gern U, Wiethölter H, Müller CA, Schoepfer R, Lindstrom J.
    Ann Neurol; 1992 Mar; 31(3):311-8. PubMed ID: 1379027
    [Abstract] [Full Text] [Related]

  • 25. T cell epitopes in experimental autoimmune myasthenia gravis of the rat: strain-specific epitopes and cross-reaction between two distinct segments of the alpha chain of the nicotinic acetylcholine receptor (Torpedo californica).
    Zhang Y, Barkas T, Juillerat M, Schwendimann B, Wekerle H.
    Eur J Immunol; 1988 Apr; 18(4):551-7. PubMed ID: 2452743
    [Abstract] [Full Text] [Related]

  • 26. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.
    Wu B, Deng C, Goluszko E, Christadoss P.
    J Immunol; 1997 Sep 15; 159(6):3016-23. PubMed ID: 9300727
    [Abstract] [Full Text] [Related]

  • 27. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.
    Kaul R, Shenoy M, Goluszko E, Christadoss P.
    J Immunol; 1994 Mar 15; 152(6):3152-7. PubMed ID: 8144909
    [Abstract] [Full Text] [Related]

  • 28. Induction of class II major histocompatibility complex blockade as well as T cell tolerance by peptides administered in soluble form.
    Nihira SI, Falcioni F, Juretic A, Bolin D, Nagy ZA.
    Eur J Immunol; 1996 Aug 15; 26(8):1736-42. PubMed ID: 8765014
    [Abstract] [Full Text] [Related]

  • 29. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX, Ma CG, Xiao BG, van de Meide PH, Link H.
    Eur J Immunol; 1996 Nov 15; 26(11):2552-8. PubMed ID: 8921938
    [Abstract] [Full Text] [Related]

  • 30. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 31. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M, Ostlie N, Lei SJ, Wu XD, Conti-Tronconi BM.
    J Immunol; 1991 Sep 01; 147(5):1484-91. PubMed ID: 1715360
    [Abstract] [Full Text] [Related]

  • 32. T cell receptor transgenic mice recognizing the immunodominant epitope of the Torpedo californica acetylcholine receptor.
    Lobito AA, Yang B, Lopes MF, Miagkov A, Adams RN, Palardy GR, Johnson MM, McFarland HI, Recher M, Drachman DB, Lenardo MJ.
    Eur J Immunol; 2002 Jul 01; 32(7):2055-67. PubMed ID: 12115627
    [Abstract] [Full Text] [Related]

  • 33. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY, Qiao J, Link H.
    J Neuroimmunol; 1993 May 01; 44(2):209-14. PubMed ID: 8505410
    [Abstract] [Full Text] [Related]

  • 34. Preferential use of a T cell receptor V beta gene by acetylcholine receptor reactive T cells from myasthenia gravis-susceptible mice.
    Infante AJ, Levcovitz H, Gordon V, Wall KA, Thompson PA, Krolick KA.
    J Immunol; 1992 Jun 01; 148(11):3385-90. PubMed ID: 1375242
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
    Dayan M, Sthoeger Z, Neiman A, Abarbanel J, Sela M, Mozes E.
    Hum Immunol; 2004 Jun 01; 65(6):571-7. PubMed ID: 15219376
    [Abstract] [Full Text] [Related]

  • 37. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    Rosenberg JS, Oshima M, Atassi MZ.
    J Immunol; 1996 Oct 01; 157(7):3192-9. PubMed ID: 8816433
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Coimmunization of MHC class II competitor peptides during experimental autoimmune myasthenia gravis induction resulted not only in a suppressed, but also in an altered immune response.
    Wauben MH, Hoedemaekers AC, Graus YM, Wagenaar JP, Van Eden W, De Baets MH.
    Ann N Y Acad Sci; 1998 May 13; 841():338-41. PubMed ID: 9668254
    [No Abstract] [Full Text] [Related]

  • 40. An altered peptide ligand inhibits the activities of matrix metalloproteinase-9 and phospholipase C, and inhibits T cell interactions with VCAM-1 induced in vivo by a myasthenogenic T cell epitope.
    Faber-Elmann A, Grabovsky V, Dayan M, Sela M, Alon R, Mozes E.
    FASEB J; 2001 Jan 13; 15(1):187-194. PubMed ID: 11149906
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.